Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

Alpha Teknova, Inc. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Alpha Teknova, Inc. pe ratio for the quarter ending 2026-06-30 was -18.12, a change of -5.9 year-over-year.
  • Alpha Teknova, Inc. pe ratio for the quarter ending 2026-03-31 was -8.93, a change of 2.98 year-over-year.
  • Alpha Teknova, Inc. pe ratio for the quarter ending 2025-12-31 was -11.76, a change of 4.91 year-over-year.
  • Alpha Teknova, Inc. pe ratio for the quarter ending 2025-09-30 was -18.15, a change of -10.01 year-over-year.
  • Alpha Teknova, Inc. pe ratio for fiscal 2026 was -18.12.
  • Alpha Teknova, Inc. pe ratio for fiscal 2025 was -11.76, a change of 4.91 from fiscal 2024.
  • Alpha Teknova, Inc. pe ratio for fiscal 2024 was -16.67, a change of -12.54 from fiscal 2023.
  • Alpha Teknova, Inc. pe ratio for fiscal 2023 was -4.14, a change of -0.79 from fiscal 2022.
Available history
2021-06-30 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-18.12$303.84M-$16.77M
2026-03-31-8.93$153.33M-$17.17M
2025-12-31-11.76$203M-$17.26M
2025-09-30-18.15$330.78M-$18.22M
2025-06-30-12.22$262.76M-$21.5M
2025-03-31-11.91$277.34M-$23.29M
2024-12-31-16.67$445.97M-$26.75M
2024-09-30-8.14$257.99M-$31.68M
2024-06-30-1.64$56.05M-$34.27M
2024-03-31-3$108.18M-$36.06M
2023-12-31-4.14$152.16M-$36.78M
2023-09-30-2.88$113.63M-$39.42M
2023-06-30-1.46$75.67M-$51.74M
2023-03-31-1.64$83.44M-$50.79M
2022-12-31-3.35$158.93M-$47.47M
2022-09-30-2.48$93.96M-$37.82M
2022-06-30-12.68$235.88M-$18.6M
2022-03-31-26.44$387.27M-$14.65M
2021-12-31-58.52$573.69M-$9.8M
2021-09-30-124.97$697.22M-$5.58M
2021-06-30-836.13$664.72M-$795,000.00

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-18.12$303.84M-$16.77M
2025-12-31-11.76$203M-$17.26M
2024-12-31-16.67$445.97M-$26.75M
2023-12-31-4.14$152.16M-$36.78M
2022-12-31-3.35$158.93M-$47.47M
2021-12-31-58.52$573.69M-$9.8M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92